Given the emerging effects of glia-derived WNT ligands on the intestinal epithelium, it is interesting that depletion of GFAP+ EGCs led to a striking reduction of tumour burden in a model of azoxymethane/DSS-induced colon cancer that was much less obvious following depletion of PLP1+ EGCs [38]. Here, GFAP is linked to neoplasm.